SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 29.33+4.6%3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JanyBlueEyes who wrote (5624)11/10/1999 9:47:00 AM
From: JanyBlueEyes  Read Replies (1) of 5736
 
Bob..........

<<On Oct 6, CCSI issued a press release which stated that they completed the shipping of 300 units to Ohmeda. No mention was made at that time of what the size of the contractual commitment was for Q4>>

<<My half empty part is that it appears Ohmeda has not increased their commitment thus reflecting a lack of robust sales. If they had you can be sure it would have been reported in the PR.>>

See press release of June 14 - Ohmeda ordered a total of 1030 devices for the 2nd half of 1999: siliconinvestor.com

<<The implication is that CCSI's products are not flying off the shelf to say the least.>>

Datex-Ohmeda is a well-known highly regarded presence in the hospital and home care market. They are developing a "Total Jaundice Management Program" with the TLc-BiliTest being the highlight of the package. You left this part out from the latest release: ".....we are now seeing the first U.S. hospitals converting to the non-invasive TLc-BiliTest(R) System as their standard of care, representing thousands of babies born each year who will have pain-free monitoring for bilirubin/infant jaundice available in the 21st century"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext